Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: Direct lymph node invasion has similar survival to node-negative disease

American Journal of Surgical Pathology

Volumn 35, Issue 2, 2011, Pages 228-234

  Pai, Rish K ^a   Beck, Andrew H ^a   Mitchem, Jonathan ^a   Linehan, David C ^a   Chang, Daniel T ^b   Norton, Jeffrey A ^b   Pai, Reetesh K ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

direct lymph node invasion; lymph node metastasis; pancreatic ductal adenocarcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 79251543680     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318206c37a     Document Type: Article

References (25)

1. Adsay NV, Basturk O, Altinel D, et al. The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional versus orange-peeling approach in pathologic assessment. Mod Pathol. 2009;22:107-112.
2. Benassai G, Mastrorilli M, Mosella F, et al. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma. J Exp Clin Cancer Res. 1999;18:23-28.
3. Berger AC, Watson JC, Ross EA, et al. The metastatic/examined lymph node ratio is an important prognostic factor after pancrea-ticoduodenectomy for pancreatic adenocarcinoma. Am Surg. 2004; 70:235-240; discussion 240.
4. Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer. 2007;110:738-744.
5. Brennan MF, Kattan MW, Klimstra D, et al. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240:293-298.
6. Breslin TM, Hess KR, Harbison DB, et al. Neoadjuvant chemor-adiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol. 2001;8:123-132.
7. Christofori G. New signals from the invasive front. Nature. 2006; 441:444-450.
8. Corsini MM, Miller RC, Haddock MG, et al. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol. 2008;26:3511-3516.
9. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. Chicago, IL: Springer; 2010.
10. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127:679-695.
11. House MG, Gonen M, Jarnagin WR, et al. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg. 2007;11:1549-1555.
12. Jemal A, Siegel R, Xu J, et al. Cancer Statistics. CA Cancer J Clin. 2010;60:277-300.
13. Konstantinidis IT, Deshpande V, Zheng H, et al. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma? J Gastrointest Surg. 2010;14:261-267.
14. Larsen JE, Pavey SJ, Bowman R, et al. Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement. Eur Respir J. 2007;30:21-25.
15. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237:74-85.
16. Mihaljevic AL, Michalski CW, Friess H, et al. Molecular mechanism of pancreatic cancer: understanding proliferation, invasion, and metastasis. Langenbecks Arch Surg. 2010;395:295-308.
17. Nagakawa T, Kobayashi H, Ueno K, et al. The pattern of lymph node involvement in carcinoma of the head of the pancreas: a histologic study of the surgical findings in patients undergoing extensive nodal dissections. Int J Pancreatol. 1993;13:15-22.
18. Nakao A, Harada A, Nonami T, et al. Lymph node metastasis in carcinoma of the body and tail of the pancreas. Br J Surg. 1997;84: 1090-1092.
19. Pawlik TM, Abdalla EK, Barnett CC, et al. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg. 2005;140:584-589; discussion 589-591.
20. Pawlik TM, Gleisner AL, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007;141:610-618.
21. Slidell MB, Chang DC, Cameron JL, et al. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol. 2008;15:165-174.
22. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567-579.
23. Team RDC. R: A Language and Environment for Statistical Computing. Vienna: Austria; 2007.
24. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreatico- duodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199-1210; discussion 1210-1191.
25. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer. 1997;80:1529-1537.